Oncology and Hematology

Oncology and Hematology Clinical Practice

Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.

Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.

Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.

977

LikeLikedUnlike

91-105 of 298

Global Perspectives on Perioperative Immunotherapy in LA HNSCC
CME/CE
Global Perspectives on Perioperative Immunotherapy in LA HNSCC
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
- Christophe Le Tourneau, MD, PhD
0.25 credits
Applying Perioperative ICIs in Clinical Practice
MinuteCE®
Applying Perioperative ICIs in Clinical Practice
- Douglas Adkins, MD
0.75 program credits
Multidisciplinary Collaboration Facilitates Multimodality Therapy
MinuteCE®
Multidisciplinary Collaboration Facilitates Multimodality Therapy
- Douglas Adkins, MD
- Ravindra Uppaluri, MD, PhD
- Nancy Lee, MD, FASTRO
0.75 program credits
Risk Stratification and Patient Selection for Perioperative ICIs
MinuteCE®
Risk Stratification and Patient Selection for Perioperative ICIs
- Douglas Adkins, MD
0.75 program credits
Rationale for Combining Radiation and Immunotherapy in Resectable Locally Advanced HNSCC
MinuteCE®
Rationale for Combining Radiation and Immunotherapy in Resectable Locally Advanced HNSCC
- Nancy Lee, MD, FASTRO
0.75 program credits
Managing Immune-Related Adverse Events in the Perioperative Setting
MinuteCE®
Managing Immune-Related Adverse Events in the Perioperative Setting
- Douglas Adkins, MD
0.75 program credits
advertisement
MinuteCE®
Advancing Care in Locally Advanced HNSCC: Integrating Perioperative Immunotherapy and Multimodal Strategies
- Douglas Adkins, MD
- Ravindra Uppaluri, MD, PhD
- Nancy Lee, MD, FASTRO
0.75 credits 7 episodes
Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
CME/CE
Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
- Robert Haddad, MD
- Ravindra Uppaluri, MD, PhD
- Nancy Lee, MD, FASTRO
0.25 credits
The Evolving Landscape of Resectable Locally Advanced HNSCC
MinuteCE®
The Evolving Landscape of Resectable Locally Advanced HNSCC
- Ravindra Uppaluri, MD, PhD
0.75 program credits
Emerging Evidence for Perioperative ICIs in Locally Advanced HNSCC
MinuteCE®
Emerging Evidence for Perioperative ICIs in Locally Advanced HNSCC
- Ravindra Uppaluri, MD, PhD
0.75 program credits
Why CELMoDs Matter in Myeloma
MinuteCE®
Why CELMoDs Matter in Myeloma
- Sagar Lonial, MD, FACP
1.00 program credits
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
MinuteCE®
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
- Joshua Richter, MD
- Sagar Lonial, MD, FACP
1.00 program credits
advertisement
Data Dive: Clinical Evidence Behind CELMoDs
MinuteCE®
Data Dive: Clinical Evidence Behind CELMoDs
- Sagar Lonial, MD, FACP
1.00 program credits
Safety First: Navigating CELMoD-Associated Toxicities
MinuteCE®
Safety First: Navigating CELMoD-Associated Toxicities
- Joshua Richter, MD
- Noopur Raje, MD
1.00 program credits
Mastering the Sequence: CELMoDs Across Treatment Lines
MinuteCE®
Mastering the Sequence: CELMoDs Across Treatment Lines
- Sagar Lonial, MD, FACP
- Noopur Raje, MD
1.00 program credits